UPDATE: Deutsche Bank Reiterates Hold Rating, Lowers PT on Laboratory Corp. of America Holdings on Weak Fundamentals, Downward EPS Revision


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


In a report published Wednesday, Deutsche Bank analyst Darren Lehrich reiterated a Hold rating on

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Laboratory Corp. of America Holdings (NYSE: LH), but lowered the price target from $110.00 to $95.00.In the report, Deutsche Bank noted, “LH sees EPS down ~7% YoY in 2014. LH offered up preliminary 2014 adjusted EPS of $6.50 or -7% YoY and 14% below FactSet consensus $7.56. The outlook calls for +2% YoY rev growth (consensus +2.1%), and implies a surprising level of margin pressure of ~200 bps lower YoY. The outlook implies adjusted EBIT margin of ~16% vs. 2013 ~18% and recent peak margin of ~20% in 2009-2010. We are adjusting EPS and PT lower, and maintain Hold given weak fundamentals. Maintain Hold.”Laboratory Corp. of America Holdings closed on Tuesday at $92.50.
Posted In: Analyst ColorPrice TargetAnalyst RatingsDarren LehrichDeutsche BankHealth CareHealth Care Services